Literature DB >> 18675433

Hypotension in preterm infants with significant patent ductus arteriosus: effects of dopamine.

Antoine Bouissou1, Thameur Rakza, Serge Klosowski, Pierre Tourneux, Marie Vanderborght, Laurent Storme.   

Abstract

OBJECTIVE: To study the effects of dopamine on systemic arterial pressure (SAP) and systemic blood flow (SBF) (estimated with the superior vena cava [SVC] flow) in preterm infants with hypotension and patent ductus arteriosus (PDA). STUDY
DESIGN: Clinical and echocardiographic variables were measured before and 2 hours after starting dopamine in premature infants <32 weeks gestational age with PDA and systemic hypotension.
RESULTS: Seventeen premature infants were included (gestational age, 28+/-2 weeks; birth weight, 1030 +/- 400 g). A mean rate of 8 +/- 2 microg/kg/min of dopamine raised SAP from 30 +/- 3 to 41 +/- 5 mm Hg (P < .05), and the pulmonary artery pressures from 25 +/- 5 to 32 +/- 8 mm Hg (P < .05). The SVC flow increased by 30% (from 130 +/- 40 to 170 +/- 44 mL/kg/min; P < .05). The left ventricular output and the end-diastolic and mean left pulmonary artery blood flow velocities did not change despite the increase in pulmonary artery pressure.
CONCLUSION: In preterm infants with hypotension and PDA, dopamine (<10 microg/kg/min) increases the systemic blood pressure and the systemic blood flow. Our results suggest that dopamine decreases left-to-right shunting across ductus arteriosus, caused by a rise in pulmonary vascular resistances.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675433     DOI: 10.1016/j.jpeds.2008.06.014

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

Review 2.  The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

Authors:  Ronald I Clyman
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

3.  Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants.

Authors:  Melissa Liebowitz; Jane Koo; Andrea Wickremasinghe; Isabel Elaine Allen; Ronald I Clyman
Journal:  J Pediatr       Date:  2016-12-01       Impact factor: 4.406

Review 4.  Persistent pulmonary hypertension of the newborn.

Authors:  Ru-Jeng Teng; Tzong-Jin Wu
Journal:  J Formos Med Assoc       Date:  2013-01-03       Impact factor: 3.282

5.  Hemodynamic effects of delayed cord clamping in premature infants.

Authors:  Ross Sommers; Barbara S Stonestreet; William Oh; Abbot Laptook; Toby Debra Yanowitz; Christina Raker; Judith Mercer
Journal:  Pediatrics       Date:  2012-02-13       Impact factor: 7.124

6.  Cerebral oxygen saturation and autoregulation during hypotension in extremely preterm infants.

Authors:  Liesbeth Thewissen; Gunnar Naulaers; Dries Hendrikx; Alexander Caicedo; Keith Barrington; Geraldine Boylan; Po-Yin Cheung; David Corcoran; Afif El-Khuffash; Aisling Garvey; Jozef Macko; Neil Marlow; Jan Miletin; Colm P F O'Donnell; John M O'Toole; Zbyněk Straňák; David Van Laere; Hana Wiedermannova; Eugene Dempsey
Journal:  Pediatr Res       Date:  2021-04-20       Impact factor: 3.756

Review 7.  Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure.

Authors:  Angel Coz Yataco; Melina Aguinaga Meza; Ketan P Buch; Margaret A Disselkamp
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

8.  An Update on Patent Ductus Arteriosus and What is Coming Next.

Authors:  Ömer Erdeve; Emel Okulu; Yogen Singh; Richard Sindelar; Mehmet Yekta Oncel; Gianluca Terrin; Giovanni Boscarino; Ali Bülbül; Hannes Sallmon; Begüm Atasay; Fahri Ovalı; Ronald I Clyman
Journal:  Turk Arch Pediatr       Date:  2022-03

9.  Observational study of cerebral hemodynamics during dopamine treatment in hypotensive ELBW infants on the first day of life.

Authors:  M H Lightburn; C H Gauss; D K Williams; J R Kaiser
Journal:  J Perinatol       Date:  2013-04-25       Impact factor: 2.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.